Etravirine (ETR) is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- In combination with other ARV agents for the treatment of HIV-1 infection in treatment-experienced pts with PIs, NRTIs, and NNRTI-resistant variants.
- Treatment-experienced HIV-infected pediatric patients (6 -18 years of age and weighing at least 16 kg).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Potential for use in first-line therapy for pts infected with NNRTI-resistant virus (untested)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: April 30, 2014
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Etravirine (ETR)
ID - 540218
A1 - Hsu,Alice,Pharm.D
AU - Pham,Paul,Pharm.D. BCPS
Y1 - 2014/04/30/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540218/all/Etravirine__ETR_
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -